News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Reed Douglas MD
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/24/2018 |
4
| Hatteras Venture Advisors III, LLC (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns:
| Converted 52,690 shares
@ $0 Converted 1,683,420 shares
@ $0 Bought 137,513 shares
@ $5, valued at
$687.6k
Converted 150,612 shares
@ $0 Bought 12,487 shares
@ $5, valued at
$62.4k
Converted 4,846 shares
@ $0 Converted 266,481 shares
@ $0 Bought 150,000 shares
@ $5, valued at
$750k
Exercised (in-or-at-the-money) 19,061 options to buy
@ $0.12, valued at
$2.3k
Exercised (in-or-at-the-money) 19,061 preferred shares
@ $0.12, valued at
$2.3k
Sold 458 preferred shares
@ $5, valued at
$2.3k
|
|
06/01/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.
Txns:
| Sold 758,290 shares
@ $48, valued at
$36.4M
Sold 41,710 shares
@ $48, valued at
$2M
|
|
05/23/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.
Txns:
| Sold 29,005 shares
@ $51.1604, valued at
$1.5M
Sold 1,595 shares
@ $51.0589, valued at
$81.4k
Sold 474 shares
@ $52.13, valued at
$24.7k
Sold 26 shares
@ $52.13, valued at
$1.4k
Sold 5,592 shares
@ $50.8593, valued at
$284.4k
Sold 308 shares
@ $50.6851, valued at
$15.6k
Sold 474 shares
@ $50.5, valued at
$23.9k
Sold 26 shares
@ $50.5, valued at
$1.3k
|
|
12/04/2017 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.
Txns:
| Disposed of 99,513 shares
@ $0 Acquired 995 shares
@ $0 |
|
05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|